SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-036655
Filing Date
2021-09-20
Accepted
2021-09-20 21:26:24
Documents
2
Period of Report
2021-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1605
2 EX-24 DOCUMENT attachment1.htm EX-24 4269
  Complete submission text file 0000899243-21-036655.txt   7493
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065
Business Address
Kelly Jason R (Reporting) CIK: 0001845677 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40097 | Film No.: 211264608